PM
52
-4
PSX
42
3
NUE
50
3
PNR
72
-2
QRVO
33
-3
EIX
69
-5
SE
65
4
MA
65
-4
SIG
58
-2
MCHP
42
-5
TSCO
55
-2
D
55
-6
PLD
51
-5
THC
61
3
MPC
44
3
NEE
52
-2
AMGN
55
-2
AN
49
2
ECL
69
-3
NTRS
47
-2
PM
52
-4
PSX
42
3
NUE
50
3
PNR
72
-2
QRVO
33
-3
EIX
69
-5
SE
65
4
MA
65
-4
SIG
58
-2
MCHP
42
-5
TSCO
55
-2
D
55
-6
PLD
51
-5
THC
61
3
MPC
44
3
NEE
52
-2
AMGN
55
-2
AN
49
2
ECL
69
-3
NTRS
47
-2
Financhill
Back

Digi International Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
50

DGII
Digi International

Last Price:
27.32
Seasonality Move:
10.69%
Sell
33

BMRN
Biomarin Pharmaceutical

Last Price:
71.48
Seasonality Move:
5.7%
Sell
50
Digi International (DGII) is a Sell

Is Digi International a Buy, Sell or Hold?

  • The current Digi International [DGII] share price is $26.67. The Score for DGII is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • DGII is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Biomarin Pharmaceutical (BMRN) is a Sell

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $71.14. The Score for BMRN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DGII Stock Price Chart

What is Digi International's stock price today?

  • The Digi International share price today is $26.67
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DGII is experiencing slight selling pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $71.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

DGII Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 45.84 Sell
Chaikin Money Flow: -12829 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.83 - 29.21) Sell
Bollinger Bands (100): (23.33 - 28.17) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 22.64 Sell
Chaikin Money Flow: 871265 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (80.02 - 93.28) Sell
Bollinger Bands (100): (78.57 - 88.29) Sell

DGII Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.53 Buy
20-day SMA: 27.83 Sell
50-day SMA: 26.69 Sell
200-day SMA: 26.81 Sell
8-day EMA: 26.77 Sell
20-day EMA: 27.2 Sell
50-day EMA: 26.8 Sell
200-day EMA: 27.18 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 79.35 Sell
20-day SMA: 85.57 Sell
50-day SMA: 85.93 Sell
200-day SMA: 87.02 Sell
8-day EMA: 77.71 Sell
20-day EMA: 82.86 Sell
50-day EMA: 84.86 Sell
200-day EMA: 86.16 Sell

Digi International Earnings Growth & DGII Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.05 per share, an increase this year of $0.01 per share, and an increase next year of $0.06 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.

Digi International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):